Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. INM has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
INM stock price ended at $2.64 on Friday, after losing-1.49%
The InMed Pharmaceuticals Inc stock price decreased by -1.49% on the last trading day (25 Jul 2025), dropping from 2.64 to 2.64. Throughout the last trading session, the stock experienced a fluctuation of 3.45% , ranging from a day low of $2.61 to a day high of 2.7. The price has declined in 5 of the last 10 days, resulting in a total change of -4.00% during this period. On the last day, trading volume increase by 298.00 shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 40.16K shares were traded, amounting to approximately 105.99K.
INM Technical Signals
INM(InMed Pharmaceuticals Inc Corp) has 3 buy signals and 4 sell signals now. The current trend is uptrend starting from 2025-05-29. The total price change during this trend is +7.76%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of INM over the last 5 trading days is 198.73K. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
INM Moving Average Analysis
InMed Pharmaceuticals Inc's overall moving average trend leans more bearish as of Saturday, July 26, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $3.30, and $3.57. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $2.41, and $2.13. A break-down below any of these levels will issue sell signals.
INM Short Selling Analysis
The short sale ratio of InMed Pharmaceuticals Inc(INM) as of 24 Jul 2025 is 20.25%, rising from last trading day. With increasing price from 2.69 to 2.68. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary
Neutral
Sell
4
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
15.278
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
13.395
Bullish
Williams %R (14 days)
WILLR_14 < -80
-88.889
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, InMed Pharmaceuticals Inc (INM) is anticipated to change hands in a trading channel between $0.00 and $0.00.
InMed Pharmaceuticals Inc Stock Forecast 2026
INM Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to InMed Pharmaceuticals Inc(INM), our algorithm predicts INM's 1-month price at $2.89, with an 8.33%upwardshift. Using a similarity score up to 94.07%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for InMed Pharmaceuticals Inc (INM.O) stock, as of Sunday, July 20, 2025 , forecasts a 8.33% change over the next month, based on its high correlation with BLFS.O stock patterns. The similarity between their price movements over the analyzed periods is 94.07%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
INM
Future prediction
Up: 8.33%
BLFS
Up: 8.33%Similarity: 94.07%
Name
Similarity
Up/Down
BLFS.O
94.07%
+8.33%
FENG.N
93.06%
-12.08%
COLM.O
92.94%
+5.31%
IDCC.O
92.79%
-7.79%
JCTC.O
92.71%
+10.17%
GIC.N
92.65%
-14.59%
CHMG.O
91.98%
+7.22%
BLMZ.O
91.95%
-27.68%
TACT.O
91.83%
+5.71%
GPUS.A
91.79%
-6.24%
INM Seasonality Analysis
Based on INM's historical stock price data across all years, the probability of a positive return in July is36.36%, suggesting it maynotbe an ideal month to invest in INM. In contrast,Januaryoffers the highest probability of positive returns at50.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying InMed Pharmaceuticals Inc (INM.O) stock in January has the highest probability of a positive return (50.00%), while September has the lowest probability (22.22%).
Performance Seasonality
The chart shows InMed Pharmaceuticals Inc. (INM)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy InMed Pharmaceuticals Inc (INM.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. INM has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying InMed Pharmaceuticals Inc (INM.O) stock in a year?
The radar chart shows that buying InMed Pharmaceuticals Inc (INM.O) stock in January has the highest probability of a positive return (50.00%), while September has the lowest probability (22.22%).
How has InMed Pharmaceuticals Inc. (INM)'s stock price performed over the past three years?
INM's stock price fell by -81.18% in 2023,decreased by -39.23% in 2024, and went down by 45%in 2025.
Is INM a buy based on overall technical signals summary?
INM has 3 buy signals and 4 sell signals now. Overall the technical rating for INM is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of INM.
What is the trend of InMed Pharmaceuticals Inc (INM)'s moving average?
InMed Pharmaceuticals Inc's overall moving average trend leans more bearish as of July 26 2025, with 3 negative signals and 1 positive signal.
What is price prediction for INM stock next month?
The price prediction chart for InMed Pharmaceuticals Inc (INM.O) stock, as of July 20 2025, forecasts a 8.33% change over the next month, based on its high correlation with BLFS stock patterns. The similarity between their price movements over the analyzed periods is 94.07%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for INM Stock?
The price prediction for INM stock in 2025 is expected to reach **$4.20** in the short term, driven by potential technical bounce from oversold conditions. However, without significant catalysts, the stock may struggle to sustain higher levels, with a lower target of **$2.50**. This prediction is based on current technical indicators and Fibonacci levels.
What is price prediction 2030 for INM Stock?
INM stock could reach $8-$12 by 2030, driven by potential breakthroughs in cannabinoid-based treatments and pipeline advancements. The stock may also drop to $0.50 if clinical trials fail or market conditions deteriorate. Current volatility and speculative nature of the biotech sector contribute to this wide price range.